news aggregator

'Natural' Sounds Improve May Improve Office Mood And Productivity

General - 1 hour 19 min ago

Playing natural sounds such as flowing water in offices could boosts worker moods and improve cognitive abilities in addition to providing speech privacy, according to a new study.

An increasing number of modern open-plan offices employ sound masking systems that raise the background sound of a room so that speech is rendered unintelligible beyond a certain distance and distractions are less annoying. Sound masking systems are custom designed for each office space by consultants and are typically installed as speaker arrays discretely tucked away in the ceiling. For the past 40 years, the standard masking signal employed is random, steady-state electronic noise -- also known as "white noise."


read more

Categories: News

'Natural' Sounds Improve May Improve Office Mood And Productivity

Science2.0 - 1 hour 19 min ago

Playing natural sounds such as flowing water in offices could boosts worker moods and improve cognitive abilities in addition to providing speech privacy, according to a new study.

An increasing number of modern open-plan offices employ sound masking systems that raise the background sound of a room so that speech is rendered unintelligible beyond a certain distance and distractions are less annoying. Sound masking systems are custom designed for each office space by consultants and are typically installed as speaker arrays discretely tucked away in the ceiling. For the past 40 years, the standard masking signal employed is random, steady-state electronic noise -- also known as "white noise."


read more

Categories: Science2.0

Enrollment For Phase 3 Trial Evaluating Azeliragon In Treatment Of Patients With Mild Alzheimer's Disease

General - 1 hour 34 min ago

Enrollment of the first patients into STEADFAST (Single Trial Evaluating Alzheimer's Disease Following Addition to Symptomatic Therapy), vTv's Phase 3 placebo controlled trial of azeliragon, an oral antagonist of the Receptor for Advanced Glycation Endproducts (RAGE) for treatment of mild Alzheimer's disease has begun. Phase 3 begins following a Phase 2 trial that demonstrated positive results in slowing cognitive decline with 5 mg/day of azeliragon in patients with mild to moderate Alzheimer's Disease.


read more

Categories: News

Enrollment For Phase 3 Trial Evaluating Azeliragon In Treatment Of Patients With Mild Alzheimer's Disease

Science2.0 - 1 hour 34 min ago

Enrollment of the first patients into STEADFAST (Single Trial Evaluating Alzheimer's Disease Following Addition to Symptomatic Therapy), vTv's Phase 3 placebo controlled trial of azeliragon, an oral antagonist of the Receptor for Advanced Glycation Endproducts (RAGE) for treatment of mild Alzheimer's disease has begun. Phase 3 begins following a Phase 2 trial that demonstrated positive results in slowing cognitive decline with 5 mg/day of azeliragon in patients with mild to moderate Alzheimer's Disease.


read more

Categories: Science2.0

Phase 2b Clinical Trial Evaluating Tenapanor In IBS-C Patients - Results

General - 1 hour 47 min ago

Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.

As previously reported, at the 50 mg dose of tenapanor, the study met its primary efficacy endpoint of an increase in the complete spontaneous bowel movement (CSBM) responder rate. Most secondary endpoints, including abdominal pain and other abdominal and IBS-C symptoms, demonstrated clinically meaningful improvements.

Tenapanor was well-tolerated, and the safety results were consistent with those observed in previous tenapanor trials.


read more

Categories: News

Phase 2b Clinical Trial Evaluating Tenapanor In IBS-C Patients - Results

Science2.0 - 1 hour 47 min ago

Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.

As previously reported, at the 50 mg dose of tenapanor, the study met its primary efficacy endpoint of an increase in the complete spontaneous bowel movement (CSBM) responder rate. Most secondary endpoints, including abdominal pain and other abdominal and IBS-C symptoms, demonstrated clinically meaningful improvements.

Tenapanor was well-tolerated, and the safety results were consistent with those observed in previous tenapanor trials.


read more

Categories: Science2.0

Early Christian Apocalypse: St. Paul Gave Us Heaven And Hell Many Times Over

Science2.0 - 2 hours 18 min ago
Early Christian writers were fond of putting words into other people’s mouths.

When the apostle Paul (the theologian formerly known as Saul of Tarsus) wrote to the church in Corinth about a particularly significant religious experience, he informed them that his journey to the “third heaven” or “Paradise” resulted in his hearing “things that are not able to be told, that no mortal is permitted to speak”.

-->

read more

Categories: Science2.0

Early Christian Apocalypse: St. Paul Gave Us Heaven And Hell Many Times Over

General - 2 hours 18 min ago
Early Christian writers were fond of putting words into other people’s mouths.

When the apostle Paul (the theologian formerly known as Saul of Tarsus) wrote to the church in Corinth about a particularly significant religious experience, he informed them that his journey to the “third heaven” or “Paradise” resulted in his hearing “things that are not able to be told, that no mortal is permitted to speak”.

-->

read more

Categories: News

UK Becoming Overweight And Obese At Younger Ages

Science2.0 - May 24, 2015 - 1:42am

Children born since the 1980s are two to three times more likely than older generations to be overweight or obese by the age of 10, according to new research published in PLOS Medicine. The study, conducted by researchers from CLOSER, a consortium of UK longitudinal studies, characterized population shifts in body mass index (BMI) using data from more than 56,000 people born in Britain from 1946 to 2001.


read more

Categories: Science2.0

UK Becoming Overweight And Obese At Younger Ages

General - May 24, 2015 - 1:42am

Children born since the 1980s are two to three times more likely than older generations to be overweight or obese by the age of 10, according to new research published in PLOS Medicine. The study, conducted by researchers from CLOSER, a consortium of UK longitudinal studies, characterized population shifts in body mass index (BMI) using data from more than 56,000 people born in Britain from 1946 to 2001.


read more

Categories: News

Antibiotic Resistance: Phages Can Transfer It In Chicken Meat

Science2.0 - May 23, 2015 - 4:30pm

Antibiotic-resistant bacteria are on the rise and they pose a global threat to public health. Common antibiotics are often ineffective in treating infectious diseases because pathogens acquire resistance genes. These antimicrobial resistance genes are obtained in different ways.

There are different explanations for how resistances are transferred and a now study found phages -
viruses that exclusively infect bacteria
- in chicken meat that are able to transfer antimicrobial resistance to bacteria.  Phages do not directly pose a risk to humans because they can only infect bacteria. No other cells or organisms can be infected.


-->

read more

Categories: Science2.0

Antibiotic Resistance: Phages Can Transfer It In Chicken Meat

General - May 23, 2015 - 4:30pm

Antibiotic-resistant bacteria are on the rise and they pose a global threat to public health. Common antibiotics are often ineffective in treating infectious diseases because pathogens acquire resistance genes. These antimicrobial resistance genes are obtained in different ways.

There are different explanations for how resistances are transferred and a now study found phages -
viruses that exclusively infect bacteria
- in chicken meat that are able to transfer antimicrobial resistance to bacteria.  Phages do not directly pose a risk to humans because they can only infect bacteria. No other cells or organisms can be infected.


-->

read more

Categories: News

Mummy Madness In The Anatomical Record - All Open Access

Science2.0 - May 23, 2015 - 3:17pm
If you like mummies (and who doesn't like mummies?) you are in luck: The Anatomical Record has a special issue with 26 articles devoted to them, all open access. You may not leave the house this weekend.
-->

read more

Categories: Science2.0

Mummy Madness In The Anatomical Record - All Open Access

General - May 23, 2015 - 3:17pm
If you like mummies (and who doesn't like mummies?) you are in luck: The Anatomical Record has a special issue with 26 articles devoted to them, all open access. You may not leave the house this weekend.
-->

read more

Categories: News

Seen And Clean: What People In Surveys Say They Want In Nutrition Labels

Science2.0 - May 23, 2015 - 3:00pm
A new survey finds that 87 percent of Americans look at the Nutrition Facts panel on packaged foods and beverages and 56 percent actively seek out nutritional information and guidelines.

67 percent favor groceries with fewer and simpler ingredients, while roughly the same percentage take nutritional content statements, ingredient-free statements, and statements about health benefits into consideration when buying packaged foods and beverages.

As is well known, food consumers who are buying for those reasons are vocal on social media, focus groups, consumer surveys, and even petitions. They say they want more transparency from the food and beverage industry and shunning artificial ingredients.
-->

read more

Categories: Science2.0

Seen And Clean: What People In Surveys Say They Want In Nutrition Labels

General - May 23, 2015 - 3:00pm
A new survey finds that 87 percent of Americans look at the Nutrition Facts panel on packaged foods and beverages and 56 percent actively seek out nutritional information and guidelines.

67 percent favor groceries with fewer and simpler ingredients, while roughly the same percentage take nutritional content statements, ingredient-free statements, and statements about health benefits into consideration when buying packaged foods and beverages.

As is well known, food consumers who are buying for those reasons are vocal on social media, focus groups, consumer surveys, and even petitions. They say they want more transparency from the food and beverage industry and shunning artificial ingredients.
-->

read more

Categories: News

The Case Of The Missing Booze: Brits Drink 12 Million More Bottles Per Week Than Previous Estimates

General - May 23, 2015 - 2:32pm
Many of us have a tipple on special occasions but including these drinks in official data has been found to increase England’s alcohol consumption by 12 million bottles of wine per week.

According to a new study published in BMC Medicine, alcohol consumption figures account for only 60% of alcohol sold in England, due to a discrepancy between self-reported consumption data and retail figures.

The new research has discovered where the missing alcohol can be found.

-->

read more

Categories: News

The Case Of The Missing Booze: Brits Drink 12 Million More Bottles Per Week Than Previous Estimates

Science2.0 - May 23, 2015 - 2:32pm
Many of us have a tipple on special occasions but including these drinks in official data has been found to increase England’s alcohol consumption by 12 million bottles of wine per week.

According to a new study published in BMC Medicine, alcohol consumption figures account for only 60% of alcohol sold in England, due to a discrepancy between self-reported consumption data and retail figures.

The new research has discovered where the missing alcohol can be found.

-->

read more

Categories: Science2.0

First Drug To Treat Radiation Sickness Approved

General - May 23, 2015 - 2:32pm
The U.S. Food and Drug Administration has approved Neupogen,  the first approved drug to treat the deleterious effects of radiation exposure following a nuclear incident. 
-->

read more

Categories: News

First Drug To Treat Radiation Sickness Approved

Science2.0 - May 23, 2015 - 2:32pm
The U.S. Food and Drug Administration has approved Neupogen,  the first approved drug to treat the deleterious effects of radiation exposure following a nuclear incident. 
-->

read more

Categories: Science2.0